RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
VIVOS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.05−0.00 (-2.51%)
Close on Oct 19, 2026
- Market cap
- $23.44M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0288 (−37.60%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
VIVOS INC grew revenue 91.5% to $99.10K over the twelve months to Jun 30, 2026. Free cash flow was -$2.16M.
Revenue
$99.10K
+91.5% vs. a year earlier
Operating income
-$2.83M
TTM Q2 2026
Free cash flow
-$2.16M
FY2025
EPS, diluted
$0.00
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $23.44M
- P/E ratio
- –
- Price to sales
- 236.54
- Price to book
- 8.51
- Dividend yield
- –
- Free cash flow yield
- -9.22%
Fundamentals
- Revenue
- $99.10K
- Net income
- -$3.60M
- EPS, diluted
- $0.00
- Free cash flow
- -$2.16M
- Book value per share
- $0.01
- Diluted shares
- 491M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$99.10K+91.5% YoY
Gross profit
-$25.66K
Operating income
-$2.83M
Net income
-$3.60M
EPS, diluted
$0.00
Free cash flow
–
Reported periodTrailing twelve months